Back

Temporal changes in FFR in initially deferred vessels in symptomatic patients

31 August 2024 (09:00 - 09:30)
Organised by: Logo
Congress Presentation Part of: Detection of microvascular dysfunction (2) Coronary Circulation, Flow, and Flow Reserve ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Rayan Shuja

Russellville (United States of America)

5 More presentations in this session

Presentation thumbnail
Predictive factors and gender insights into abnormal myocardial flow reserve in non-obstructive coronary artery disease: a CZT-SPECT analysis
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Coronary physiology: no complete diagnosis without acteylcholine
Doctor D. O h-Ici (Galway, IE)
Abstract Slides Video
Presentation thumbnail
The influence of epicardial resistance on Microvascular Resistance Reserve (MRR)
Doctor T. Mahendiran (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
The relationship between coronary microvascular dysfunction and left ventricular longitudinal systolic function in patients with diabetes mellitus
Professor Y. Wang (Kunming, CN)
Abstract Slides Video
Presentation thumbnail
Coexistence of coronary microvascular dysfunction and left ventricular hypertrophy can predict prognosis of patients with nonobstructive coronary arteries.
Doctor A. Ito (Yokosuka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Detection of microvascular dysfunction (2)

The Event

Event poster

ESC Congress 2024

31 August 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Is it safe to defer revascularisation in asymptomatic patients with chronic coronary syndrome with FFR-CT positive stenoses?
thumbnail
Congress Session
Functional testing in coronary artery disease
thumbnail
Congress Session
Clinical trial updates on intervention and acute coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources